Establishing In Vitro Models for Cancer Research
Corresponding Organization :
Other organizations : University of California, San Diego, Celldex Therapeutics (United States)
Variable analysis
- Cisplatin (Enzo Biosciences)
- Paclitaxel (Sigma)
- MMAE (Concortis)
- Clinical-grade CDX3379 (provided by Celldex)
- Clinical grade cetuximab (Erbitux, Lilly Medical)
- Not explicitly mentioned
- Cell lines: CAL27 (CRL2095), Detroit 562 (CCL-138), LL/2 (CRL-1642), B16 (CRL-6475), MC38 (ENH204-FP), MOC1, MOC2, CAL27 PIK3CA H1047R, 4MOSC1
- Cell culture conditions: DMEM (Gibco) supplemented with 10% FBS (Omega Scientific), IMDM (Lonza)/F-12K nutrient mixture at a 2:1 mixture with 5% FBS, 5 ng/ml EGF (EMD Millipore), 400 ng/ml hydrocortisone (Sigma), and 5 mg/ml insulin (Sigma)
- Mycoplasma testing
- Not explicitly mentioned
- Not explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!